Home530239 • BOM
Suven Life Sciences Ltd
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 14.67M | -38.50% |
Operating expense | 466.34M | 40.71% |
Net income | -439.45M | -65.58% |
Net profit margin | -3.00K | -169.21% |
Earnings per share | — | — |
EBITDA | -438.41M | -45.48% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 600.05M | -74.98% |
Total assets | 1.35B | -52.55% |
Total liabilities | 251.97M | 69.54% |
Total equity | 1.10B | — |
Shares outstanding | 217.55M | — |
Price to book | 57.15 | — |
Return on assets | — | — |
Return on capital | -74.56% | — |
Cash Flow
Net Change in Cash
Net change in cash
(INR) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -439.45M | -65.58% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
₹289.20
Day range
₹281.10 - ₹294.75
Year range
₹102.70 - ₹303.00
Market cap
65.79B INR
Avg Volume
62.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
About
Founded
1989
Website
Employees
141